Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 506 entries
View as:

Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00107523 Org: User:
Start: 01/31/05 End: 10/31/05 Due: 10/31/06

Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05936229 Org: User:
Start: 04/01/25 End: 10/30/27 Due: 10/30/28

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00217438 Org: User:
Start: 07/31/05 End: - Due: -

PATH Partnering to Achieve Tobacco-free Health

Phase: N/A Priority: Normal
NCT ID: NCT01533974 Org: User:
Start: 06/30/11 End: 01/31/15 Due: 01/31/16

Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00016068 Org: User:
Start: 01/31/01 End: 09/30/07 Due: 09/30/08

CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01881867 Org: User:
Start: 09/10/13 End: 01/02/18 Due: 01/02/19

Yeego! Healthy Eating & Gardening School-Based Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT03778021 Org: User:
Start: 08/05/19 End: 08/31/21 Due: 08/31/22

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00489203 Org: User:
Start: 04/30/07 End: - Due: -

Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS

Phase: N/A Priority: Normal
NCT ID: NCT01141725 Org: User:
Start: 09/30/10 End: 11/30/12 Due: 11/30/13

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00408681 Org: User:
Start: 06/30/06 End: 05/01/15 Due: 05/01/16

Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01236885 Org: User:
Start: 12/31/12 End: - Due: -

Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01758484 Org: User:
Start: 04/30/13 End: - Due: -

Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01678443 Org: User:
Start: 09/01/99 End: 09/27/18 Due: 09/27/19

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00005803 Org: User:
Start: 09/30/99 End: 10/31/18 Due: 10/31/19

Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education

Phase: N/A Priority: Normal
NCT ID: NCT06995924 Org: User:
Start: 07/01/25 End: 12/31/26 Due: 12/31/27

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

Phase: N/A Priority: Normal
NCT ID: NCT06926062 Org: User:
Start: 07/01/25 End: 10/01/26 Due: 10/01/27

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04579523 Org: User:
Start: 09/01/25 End: 12/31/28 Due: 12/31/29

A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05835154 Org: User:
Start: 06/30/25 End: 08/31/25 Due: 08/31/26

iCanQuit Smoking Cessation Among Hispanic Adults

Phase: N/A Priority: Normal
NCT ID: NCT06811038 Org: User:
Start: 07/01/25 End: 07/01/30 Due: 07/01/31

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01865617 Org: User:
Start: 05/22/13 End: 03/26/21 Due: 03/26/22

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00002456 Org: User:
Start: 05/31/86 End: 04/30/02 Due: 04/30/03

Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003868 Org: User:
Start: 02/28/99 End: 03/31/05 Due: 03/31/06

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00060424 Org: User:
Start: 03/31/03 End: 09/22/10 Due: 09/22/11

Screening Mammography and Latinas: A Multilevel Intervention

Phase: N/A Priority: Normal
NCT ID: NCT02010008 Org: User:
Start: 05/31/10 End: 04/30/15 Due: 04/30/16

Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00005802 Org: User:
Start: 06/30/99 End: 03/31/05 Due: 03/31/06